Drug therapy for pulmonary nontuberculous mycobacterial disease

Ho Namkoong, Naoki Hasegawa

Research output: Contribution to journalArticle

Abstract

A definite strategy for pulmonary nontuberculous mycobacterial (NTM) disease has not been established yet. For this reason, pulmonary physicians are frequently distressed in the clinical setting. The standard chemotherapy agents used for pulmonary Mycobacterium avium complex, the most common NTM in Japan, are clarithromycin, rifampicin, and ethambutol. In this manuscript as well as in the standard chemotherapy for pulmonary NTM disease, we review various clinical problems that are not included in the guidelines and new drugs that are expected to be launched in the future.

Original languageEnglish
Pages (from-to)1084-1094
Number of pages11
JournalJapanese Journal of Chest Diseases
Volume74
Issue number10
Publication statusPublished - 2015 Oct 1

Keywords

  • Drug therapy
  • MAC/nontuberculous mycobacteria
  • Mycobacterium avium complex

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Fingerprint Dive into the research topics of 'Drug therapy for pulmonary nontuberculous mycobacterial disease'. Together they form a unique fingerprint.

  • Cite this